Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Shortage of an active ingredient

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0054-0371-25
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)
Initial Posting
Jul 14, 2023

Reason

Shortage of an active ingredient

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.